The Canadian/US Integrative Oncology Study (CUSIOS): Advanced Integrative Oncology Treatment for Stage 4 Cancer Patients: A Prospective Outcomes Study
Published November 13, 2022
Principle Investigators: Leanna J. Standish, ND, PhD, LAc, FABNO; Dugald Seeley, ND, MSc
ClinicalTrials.gov Identifier: NCT02494037
This study describes the survival outcomes of advanced stage breast, colorectal, ovarian and pancreatic cancer patients receiving advanced integrative oncology (AIO) treatment at participating North American integrative oncology clinics. This study also aims to describe the integrative treatments recommended by naturopathic doctors (NDs) for these participants alongside their conventional care treatments. Sub-studies will evaluate health-related quality of life, cost of cancer care, and qualitative experience of care in a subset of Canadian participants.